Women's Health Innovation Summit 2021 | Kisaco Research

Women's Health Innovation Summit

Accelerating innovation, investment, research and partnerships, to improve the access and quality of healthcare for women worldwide.

Download 2020 Agenda
Boston USA / Virtual Day (Sept 28)
14-15 September, 2021

“This summit is a wonderful opportunity to learn about exciting innovations on the horizon and connect with potential collaborators in Women's Health.”

Allison Conti, Watkins-Conti Products

WHI 2021 STEERING COMMITTEE


WHY ATTEND?

Women’s Health is a critically underserved industry, with a plethora of unmet needs, under-researched diseases, and lack of innovative solutions and approaches.

The Women’s Health Innovation Summit is the sector’s leading platform committed to strengthening the network, tackling unmet needs and championing innovative approaches and solutions. Our focus is not only on female-only health challenges, but female-prevalent diseases and those conditions that affect or present differently in women.

With so many differing health challenges across a woman’s life, our flagship summit brings together all the critical stakeholders together to focus on the intersections and sector-straddling challenges, with the ambition of ‘moving the needle’ toward improved outcomes in women’s health.

In 2021 these leadership discussions include:

  • Creating Opportunities for Investment and Scaling Women’s Health Start-Ups (Femtech).
  • Technological Advances and the Role of Digitization in advancing the sector.
  • The impact of COVID-19 on Women and Women’s Health, and the fall-out to come for the industry and the patient.
  • Latest Innovator’s & Entrepreneur Solutions showcased in our Women’s Health Innovation Spotlight.
  • Novel Care Models and Approaches; including moving to holistic, personalized or precision based models.  
  • Access to Care and Treatment for Women in the USA.

Join our leading network of pharmaceuticals, biotech’s, medical device companies, start-ups, Femtech, insurers, CRO’s, investors, researchers, HCP’s and advocacy groups, to drive innovation at the convergence of healthcare and technology.

This year, the Women’s Health Innovation Summit will include both face-to-face and virtual components to reflect our global community. Attend in person on September 14-15 in Boston or join virtually on September 28 for high-level live discussions, on-demand content from across the series, and the opportunity to connect and have meetings with other attendees.

2021 Partners

Associate Partner

KNOWLEDGE PARTNER

Event Partner

Media Partners

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

AUDIENCE BREAKDOWN

5%
Non-profits/ Advocacy Groups
10%
Investor/Funding Groups
8%
Payors/ Providers/ Employers
35%
Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs
30%
Start Ups/ Femtech/ Entrepreneurs/ Innovation
12%
Service Providers

Non-profits/ Advocacy Groups

Investor/Funding Groups

Payors/ Providers/ Employers

Pharmaceutical Companies/ Medical Device & Diagnostics/Biotechs

Start Ups/ Femtech/ Entrepreneurs/ Innovation

Service Providers

2021 Series Speakers

 

Jill Angelo

CEO and Founder
Gennev

Jill Angelo

CEO and Founder
Gennev

Jill Angelo

CEO and Founder
Gennev
 

Dr. Barb DePree

Director of Holland Hospital, Women's Health
Holland Hospital

Dr. Barb DePree

Director of Holland Hospital, Women's Health
Holland Hospital

Dr. Barb DePree

Director of Holland Hospital, Women's Health
Holland Hospital
 

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.


As the leader of the Bayer Women’s Healthcare team, he is responsible for Bayer’s leading contraceptive portfolio, with revenues in excess of 900m$ and leading a cross-functional organization of more than 300 team members.
In his previous role, Nelson led the Bayer Pharmaceuticals team in Australia and New Zealand, where he was responsible for the launch of blockbuster drugs including Xarelto (cardiovascular) and Eylea (ophthalmology) and guiding a team of more than 250 people.


Nelson’s career spans more than 20 years with Bayer and Schering in both mature and emerging markets across Latin America, Europe and Australasia. He has held the position of managing director of Bayer Portugal, business unit director General Medicine, Bayer Brazil and assistant to a Bayer Board Member at the company’s headquarters in Germany.
Nelson started his career at Schering in his native Uruguay and was instrumental in the program management of the Bayer-Schering integration in Latin America and Canada.

 

Dr. Jane van Dis, MD

Lead FemTechII Fund
Portfolia

Dr. Jane van Dis, MD

Lead FemTechII Fund
Portfolia

Dr. Jane van Dis, MD

Lead FemTechII Fund
Portfolia
 

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan

Reenita Das

Partner
Frost & Sullivan
 

Beth Battaglino

CEO
HealthyWomen

Beth Battaglino

CEO
HealthyWomen

Beth Battaglino

CEO
HealthyWomen
 

Dr. Brian A. Bernick

Co-Founder & Chief Scientific Officer
TherapeuticsMD

Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics.  Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania.  Thereafter, Dr.

Dr. Brian A. Bernick

Co-Founder & Chief Scientific Officer
TherapeuticsMD

Dr. Brian A. Bernick

Co-Founder & Chief Scientific Officer
TherapeuticsMD

Dr. Brian Bernick is a graduate of Northwestern University where he was pre-med and earned a degree in economics.  Dr. Bernick graduated from Chicago Medical School and then went on to specialize in obstetrics and gynecology, completing his residency through the University of Pennsylvania.  Thereafter, Dr. Bernick spent over 20 years in private practice in Boca Raton, Florida.  During that time, he served as the Chairman of the Department of Obstetrics and Gynecology at Boca Raton Regional Hospital and as an associate professor at Florida Atlantic University College of Medicine.  In 2008, Dr. Bernick co-founded TherapeuticsMD, a woman’s healthcare company where he has remained part of the executive management and oversees product development and outreach with healthcare providers.  TherapeuticsMD is a NASDAQ traded pharmaceutical company with prescription drug products ranging from prenatal care, contraception and menopause. In 2018, TherapeuticsMD obtained 3 new drug approvals. Dr. Bernick is the recipient of several national and regional awards, including recognition by his peers as one of the top doctor’s in his specialty. Dr. Bernick has over 100 peer-reviewed publications and presentations of original research at medical conferences. Dr. Bernick holds over 40 US and foreign patents focusing on drug therapies and analysis.  Dr. Bernick resides in Boca Raton, Florida with his wife and two kids.

 

 

 

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds

David Sable

Healthcare and Life Sciences Portfolio Manager
Special Situations Funds
 

Barbara Collura

President CEO
RESOLVE

Barbara Collura

President CEO
RESOLVE

Barbara Collura

President CEO
RESOLVE
 

Lindsey Conon

Group Vice President, Account Management
Progyny

Lindsey Conon

Group Vice President, Account Management
Progyny

Lindsey Conon

Group Vice President, Account Management
Progyny
 

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio

Evan Sussman

Chief Executive Officer, Co-Founder
Granata Bio
 

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures
 

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures

Elizabeth Bailey

Managing Director
Rhia Ventures
 

Sabrina Johnson

President & CEO
Daré Bioscience

Sabrina Johnson

President & CEO
Daré Bioscience

Sabrina Johnson

President & CEO
Daré Bioscience
 

Kelly Ketterson

Vice President, Medical Affairs – Americas
Cooper Surgical

Kelly Ketterson

Vice President, Medical Affairs – Americas
Cooper Surgical

Kelly Ketterson

Vice President, Medical Affairs – Americas
Cooper Surgical
 

Gregory S. Kopf, PhD

Director, Research and Development, Contraceptive Technology Innovation
FHI£60

Gregory S. Kopf, PhD

Director, Research and Development, Contraceptive Technology Innovation
FHI£60

Gregory S. Kopf, PhD

Director, Research and Development, Contraceptive Technology Innovation
FHI£60
 

Eva Lathrop, MD, MPH

Global Medical Director
Public Services International

Eva Lathrop, MD, MPH

Global Medical Director
Public Services International

Eva Lathrop, MD, MPH

Global Medical Director
Public Services International
 

David Feigal

Partner
Ex FDA, NDA Partners

David Feigal

Partner
Ex FDA, NDA Partners

David Feigal

Partner
Ex FDA, NDA Partners
 

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good.  She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr.

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good.  She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr. Noori is a 2019 scholar at Flare Capital Partners in Boston, MA.

 

Aside from her endeavors in digital health, Dr. Noori deeply cares about the wellbeing of women. She is the co-founder of the Women’s Mental Health Conference at Yale, the first trainee-led women’s mental health conference in the world.  Dr. Noori also co-founded the Yale Women’s Housestaff Organization, which advocates for improved working conditions for the over 700 women residents and fellows at Yale.

 

Dr. Noori is an MD graduate of the PRIME program at UCSF School of Medicine, a dual-degree program that trains emerging physician-leaders to transform care for underserved populations. She received her MPH in health policy and management at UC Berkeley. She is passionate about women’s mental health and the use of technology to improve health equity.  

 

 

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine

Lisa Larkin

CEO & Founder
Ms Medicine
 

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent, CEO, joined Atlantic Therapeutics in December 2019, leading the successful DTC launch of INNOVO® in the US and quickly demonstrating the scale-up potential of the brand. Prior to Atlantic Therapeutics, Susan spent 20+ years at GSK, building deep Pharmaceutical and Consumer Healthcare experience including the switch and transformation of Rx products into high-growth direct-to-consumer brands in weight control, smoking control, and skincare. Multi-market General Management, Marketing and BD leadership roles across Europe, US and Asia.

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent

CEO
Atlantic Therapeutics

Susan Trent, CEO, joined Atlantic Therapeutics in December 2019, leading the successful DTC launch of INNOVO® in the US and quickly demonstrating the scale-up potential of the brand. Prior to Atlantic Therapeutics, Susan spent 20+ years at GSK, building deep Pharmaceutical and Consumer Healthcare experience including the switch and transformation of Rx products into high-growth direct-to-consumer brands in weight control, smoking control, and skincare. Multi-market General Management, Marketing and BD leadership roles across Europe, US and Asia.

INNOVATION SPOTLIGHT 2021

The Women’s Health Innovation team are proud to announce the continuation of this prestigious ‘spotlight’ opportunity for the entrepreneurs and innovators in Women’s Health.

10 Finalists chosen by our Selection Committee, will present their company on both the Boston and virtual stage this September in a quick-fire round of presentations.

We are looking to hear 10 unique perspectives on the future of Women’s Health, and what your companies’ role is in that journey. Our platform is about giving a voice to the innovation that will ‘move the needle’ in Women’s Health and putting that in front of the decision-makers that can accelerate that vision.

We are seeking Femtech and Women’s Health companies providing a product, solution or service geared to helping women lead better lives. The application is stage agnostic and we are invested in the idea and ambition of the start-ups putting themselves forward.

Submission Deadline: July 30th. All applicants receive $100 off their ticket!

TOP TIP: The more detailed your application form, the more information the selection committee can use to make their decision. All applications are confidential and details will not be shared beyond the committee. However, if you do not wish to fill in a question, please feel free to leave it blank.

APPLY HERE

WHI Spotlight Innovation Selection Committee 2021

Author:

Elizabeth Bailey

Managing Director
Rhia Ventures

Author:

Christina Jenkins

Venture Investor and Strategic Advisor
Portfolia

Christina Jenkins MD is a venture investor and strategic advisor with expertise spanning clinical medicine, venture capital, health systems, and managed care organizations. Her knowledge of healthcare providers, payers, and consumers enables successful innovation, growth, and improved outcomes. 

 

As a Venture Partner for Portfolia’s FemTech and Active Aging and Longevity Funds, Dr. Jenkins invests in early-stage companies targeting women’s health, or that seek to leverage women’s role as primary health decisionmaker and caregiver.  

 

She also serves as Executive Advisor for Lucania Partners, working alongside healthcare leaders to implement growth and redesign strategies. Previously, Dr. Jenkins was the founding CEO of OneCity Health Services, a subsidiary of NYC Health + Hospitals (H+H) built to establish population health and value-based payment capabilities for 1M lives.  

 

Dr. Jenkins is a Board Director for Independence Health Group (parent of Independence Blue Cross), a Board Observer for Madorra, and an advisor to value-generating healthcare companies including Visiting Nurse Service of New York, Elektra, Incredible Health, Babyscripts, and Wellth. 

Author:

Maria Velissaris

Founding Partner
Steel Sky Ventures

Author:

Jessica Federer

Former- CDO at Bayer & Venture Partner
Boston Millennia Partners

Author:

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Download 2020 agenda

Please complete the form to access the 2020 Women's Health Innovation Summit (WHIS) Agenda and register your interest to WHIS 2021. 

Take a look at 2019 highlights:

REGISTER YOUR INTEREST FOR WOMEN'S HEALTH INNOVATION 2021

REGISTRATION

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:

TICKET PRICES INCREASE IN

Monday, May 10, 2021 to Friday, November 19, 2021
Emerging - VIRTUAL ONLY
$499
For FemTech and Digital Health Companies, incl. Venture Capitalists and Angel Investors (with less than $10 million annual revenue)
Access to all virtual and on-demand content
1-2-1 video networking meetings
Access to content 2 months post event
Monday, May 10, 2021 to Friday, July 9, 2021
Emerging
$799
Super Early Bird rate until July 9th (Standard price $1199)
For FemTech and Digital Health Companies, incl. Venture Capitalists and Angel Investors (with less than $10 million annual revenue)
2 Day In-Person Conference Pass
Access to all virtual and on-demand content
In-Person networking opportunities and access to virtual networking platform
To increase your brand presence, contact Nathan Edwards: [email protected]
Monday, May 10, 2021 to Friday, November 19, 2021
Industry - VIRTUAL ONLY
$1099
For Pharma, Biotech, Medical Devices, Diagnostics, Multinational and Corporate (with over $10 million annual revenue)
Access to all virtual and on-demand content
1-2-1 video networking meetings
Access to content 2 months post event
Monday, May 10, 2021 to Friday, July 9, 2021
Industry
$1499
Super Early Bird rate until July 9th (Standard price $1999)
For Pharma, Biotech, Medical Devices, Diagnostics, Multinational and Corporate (with over $10 million annual revenue)
2 Day In-Person Conference Pass
Access to all virtual and on-demand content
In-Person networking opportunities and access to virtual networking platform
To increase your brand presence, contact Nathan Edwards: [email protected]
Monday, May 10, 2021 to Friday, November 19, 2021
Service Providers - VIRTUAL ONLY
$1299
For Consultants, Industry Vendors, Investment Banks and Private Equity Firms 
Access to all virtual and on-demand content
1-2-1 video networking video meetings
Access to content 2 months post event
Monday, May 10, 2021 to Friday, July 9, 2021
Service Providers
$1799
Super Early Bird rate until July 9th (Standard price $2199)
For Consultants, Industry Vendors, Investment Banks and Private Equity Firms 
2 Day In-Person Conference Pass
Access to all virtual and on-demand content
In-Person networking opportunities and access to virtual networking platform
To increase your brand presence, contact Nathan Edwards: [email protected]
Preparing registration...

Returning Safely Measures

Whether sponsors, speakers or attendees, our customers attend Kisaco Research events to connect, learn and innovate to know more and do business. It is our commitment that as we return to in-person events, they can do this effectively, safely and with confidence.

All in-person Kisaco Research events will prioritize the health and safety of colleagues and customers and, in the first instance, will be run in accordance with official government and local authority guidance, as well as any venue or location-specific regulations.

Kisaco Research is committed to following the Association of Event Organisers All Secure Standard, which has been approved by by UK Government.

Download the Kisaco Research Returning Safely Measures 

Venue

Venue

Hilton Boston Back Bay, 40 Dalton Street, Boston, MA, 02115


Book your room! 

Hilton Boston Back Bay

Arrival Date: 13-Sep-2021

Departure Date: 15-Sep-2021

Quote WOMENS HEALTH INNOVATION to book at the special group rate. 

Book here. 

 

 

 

 

RESOURCES

Download Resource

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Contact Us

Other events you might be interested in:

Women's Health Innovation Series: Women 40+ Innovation Summit